Replies to post #97524 on Biotech Values

[DewDiligence]

NVS/TEVA/BIIB/ELN/MNTA:

…a survey conducted by Oppenheimer in which 26 neurologists treating more than 100 MS patients were asked how Gilenia will change treatment paradigm. I'm too tired to translate now and hopefully there will be an English version tomorrow…

Can you give us just the numbers? They ought to be easy to translate :- )